Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Androgens may block hair growth signals, targeting this could treat hair loss.

Different factors help diagnose and treat hair loss accurately.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Spironolactone and minoxidil together effectively treat female pattern hair loss.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Substance from human umbilical cord blood cells promotes hair growth.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Alternative treatments show promise for hair growth beyond traditional methods.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

Lower growth factors linked to balding in androgenetic alopecia.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

High uric acid levels link to male pattern baldness, especially in young men.

Stromal Vascular Fraction treatment increases hair density and thickness, making it a safe and effective treatment for Androgenetic Alopecia.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

FPHL affects hair density and diameter, causing visible hair loss in older women.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.